Padua Score - VTE Risk
Padua Score assesses VTE risk in medical inpatients. Score ≥4 indicates high risk requiring pharmacological prophylaxis.
Did our AI summary help? Let us know.
Padua ≥4: pharmacological prophylaxis Assess bleeding risk with HAS-BLED Multiple models for validation
Ready to run the numbers?
Why: VTE is a leading cause of preventable hospital death. Risk stratification guides prophylaxis decisions.
How: Enter patient demographics and risk factors. Padua, Caprini, Rogers, Khorana, and HAS-BLED are calculated.
Run the calculator when you are ready.
🏥 Low Risk Medical Patient
Young medical patient with minimal VTE risk factors, mechanical prophylaxis indicated
Click to load
🎗️ High Risk Oncology Patient
Cancer patient with multiple VTE risk factors requiring pharmacological prophylaxis
Click to load
⚕️ Major Surgery Patient
Post-operative patient with moderate VTE risk requiring extended prophylaxis
Click to load
🚨 ICU Critical Patient
Critically ill patient with multiple comorbidities and highest VTE risk
Click to load
🤱 Pregnancy-Related VTE
Pregnant patient with inherited thrombophilia requiring specialized assessment
Click to load
Patient Assessment
Demographics
VTE Risk Factors (Padua Score)
Bleeding Risk Factors (HAS-BLED)
Clinical Context
For informational purposes only — not medical advice. Consult a healthcare professional before acting on results.
🏥 Health Facts
VTE risk in medical inpatients
— Clinical
Validated prediction model
— Research
What is the Padua Score VTE Risk Assessment Calculator?
The Padua Score is a clinically validated prediction model that accurately assesses venous thromboembolism (VTE) risk in hospitalized medical patients. Developed through extensive research and validated across multiple healthcare systems, this evidence-based tool helps healthcare professionals identify patients at high risk for dangerous blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Our advanced calculator transforms the traditional Padua Score into a comprehensive digital health assessment tool, integrating multiple validated risk models, bleeding risk evaluation, and personalized clinical recommendations.
🏥 Understanding VTE Risk Assessment
What is VTE?
Venous thromboembolism encompasses two life-threatening conditions: deep vein thrombosis (DVT) where blood clots form in deep veins, and pulmonary embolism (PE) where clots travel to the lungs. VTE affects over 900,000 Americans annually and is the third most common vascular disease after heart attack and stroke.
Why Risk Assessment Matters
Proper VTE risk stratification saves lives by identifying patients who need prophylactic anticoagulation. Studies show that appropriate thromboprophylaxis reduces VTE incidence by up to 70% in high-risk hospitalized patients, significantly improving patient outcomes and reducing healthcare costs.
Multiple Validated Risk Models
Cross-validation using four evidence-based VTE risk assessment models: Padua Score for medical patients, Caprini Score for surgical cases, Rogers Score for post-operative assessment, and Khorana Score for cancer patients.
Validation Studies:
- Padua Score: 1,180 patients (Barbar 2010)
- Caprini Score: >10,000 patients validated
- Rogers Score: Surgical population focus
- Khorana Score: Cancer-specific validation
HAS-BLED Bleeding Risk Assessment
Integrated bleeding risk evaluation using the internationally validated HAS-BLED score ensures optimal risk-benefit analysis for anticoagulation therapy decisions. This dual assessment prevents both thrombotic and hemorrhagic complications.
HAS-BLED Components:
- Hypertension & organ dysfunction
- Stroke & bleeding history
- Labile INR & elderly status
- Drug/alcohol interactions
Evidence-Based Decision Support
Comprehensive clinical recommendations based on current guidelines from CHEST, ACCP, and ESC. Provides specific prophylaxis protocols, contraindication assessments, and alternative management strategies for complex patients.
Clinical Features:
- Prophylaxis type & duration
- Contraindication evaluation
- Alternative therapy options
- Net clinical benefit analysis
⚡ Why Our Calculator is Superior
vs. Basic Padua Score Tools
- ✓ Multiple risk model integration
- ✓ Bleeding risk assessment included
- ✓ Interactive visualizations
- ✓ AI-powered insights
Clinical Advantages
- ✓ Comprehensive patient assessment
- ✓ Evidence-based recommendations
- ✓ Risk-benefit optimization
- ✓ Professional-grade accuracy
How Does Advanced Padua Score Assessment Work?
Our advanced Padua Score calculator employs a sophisticated multi-model approach that combines validated VTE risk assessment tools with bleeding risk stratification. The system evaluates 11 core risk factors according to the original Padua Score, while simultaneously assessing bleeding risk using the HAS-BLED score, providing comprehensive clinical decision support for optimal patient care.
🔬 Scientific Methodology
Assessment Process
- 1Systematic evaluation of 11 validated VTE risk factors
- 2Concurrent bleeding risk assessment using HAS-BLED score
- 3Cross-validation with multiple risk assessment models
- 4Net clinical benefit analysis and personalized recommendations
Why This Approach Works
- Validated in multiple clinical populations
- Balances VTE prevention with bleeding risk
- Provides specific clinical recommendations
- Supports evidence-based clinical decision-making
Padua Score Assessment
Uses 11 validated risk factors with specific point values to identify patients with ≥4 points as high VTE risk requiring thromboprophylaxis.
HAS-BLED Bleeding Risk
Evaluates 9 bleeding risk factors to identify patients with ≥3 points as high bleeding risk, guiding anticoagulation decisions.
Clinical Decision Support
Integrates multiple risk models to provide evidence-based recommendations for thromboprophylaxis, mechanical prophylaxis, or observation.
🧮 Advanced Assessment Algorithm
Primary Assessment Process
Risk Factor Collection
Systematic evaluation of 11 Padua Score risk factors with evidence-based point assignment
Score Calculation
Mathematical summation of individual risk factor points to generate total score
Risk Stratification
Classification into low (<4 points) or high risk (≥4 points) categories
Secondary Validation
Bleeding Risk Assessment
Concurrent HAS-BLED score calculation to evaluate anticoagulation safety
Net Clinical Benefit
Mathematical analysis of VTE risk reduction versus bleeding risk increase
Clinical Recommendations
Evidence-based guidance for thromboprophylaxis, mechanical prophylaxis, or observation
Padua Score Calculation Formulas and Step-by-Step Guide
The Padua Prediction Score uses an evidence-based point system to quantify VTE risk through systematic evaluation of 11 clinical risk factors. Each factor is assigned specific point values based on extensive clinical research and validation studies. Understanding these calculations ensures accurate risk assessment and appropriate clinical decision-making for thromboprophylaxis.
📋 Complete Padua Score Risk Factor Table
| Risk Factor | Points | Clinical Definition |
|---|---|---|
| Active Cancer | 3 | Patients with cancer excluding basal cell or squamous cell carcinoma of the skin |
| Previous VTE | 3 | History of deep vein thrombosis or pulmonary embolism |
| Reduced Mobility | 3 | Bed rest with bathroom privileges for ≥3 days |
| Known Thrombophilia | 3 | Inherited thrombophilic condition |
| Recent Trauma/Surgery | 2 | Trauma or surgery within 1 month |
| Age ≥70 years | 1 | Elderly patients with increased baseline VTE risk |
| Heart/Respiratory Failure | 1 | Acute or chronic heart failure, respiratory failure |
| Acute MI/Stroke | 1 | Acute myocardial infarction or ischemic stroke |
| Acute Infection | 1 | Acute infection or sepsis |
| Rheumatologic Disorder | 1 | Acute rheumatologic disorder |
| Obesity (BMI ≥30) | 1 | Body mass index ≥30 kg/m² |
1. Core Padua Score Calculation
Range: 0-20 points
Threshold: ≥4 points = High Risk
Patient with: Active Cancer (3) + Age ≥70 (1) + Obesity (1) = 5 points → High Risk
2. HAS-BLED Bleeding Risk Score
H: Hypertension (1 point)
A: Abnormal renal/liver function (1 point each)
S: Stroke history (1 point)
B: Bleeding tendency/history (1 point)
L: Labile INR (1 point)
E: Elderly age >65 (1 point)
D: Drugs/alcohol (1 point each)
3. VTE Risk Stratification
Low Risk: Padua Score < 4 points (0.3% VTE incidence)
High Risk: Padua Score ≥ 4 points (11.0% VTE incidence)
4. Net Clinical Benefit Analysis
Favorable: VTE risk > 2 × Bleeding risk
Marginal: VTE risk = 1.5-2 × Bleeding risk
Unfavorable: VTE risk ≤ Bleeding risk
🔬 Step-by-Step Calculation Process
Assessment Steps
- 1Evaluate all 11 Padua risk factors systematically
- 2Sum individual point values for total score
- 3Calculate HAS-BLED bleeding risk score
- 4Determine net clinical benefit ratio
- 5Generate evidence-based recommendations
Clinical Examples
Low Risk Example:
65-year-old with pneumonia: Age <70 (0) + Infection (1) = 1 point → No prophylaxis needed
High Risk Example:
75-year-old cancer patient: Age ≥70 (1) + Cancer (3) + Reduced mobility (3) = 7 points → Prophylaxis indicated
When to Use the Padua Score Calculator
The Padua Score calculator is specifically designed for VTE risk assessment in hospitalized medical patients. It should be used systematically for all medical admissions to guide thromboprophylaxis decisions, particularly in patients without clear contraindications to anticoagulation. The calculator is most valuable during admission assessment, clinical status changes, and before discharge planning to ensure appropriate prophylactic interventions are implemented throughout the hospital stay.
🏥 Clinical Implementation Timeline
Admission Assessment
Within 24 hours of medical admission, evaluate all risk factors systematically
Status Changes
Reassess when clinical condition, mobility, or treatment plans change significantly
Discharge Planning
Review risk status and determine need for extended prophylaxis or follow-up
Medical Admissions
Systematic VTE risk assessment for all medical admissions, particularly patients with acute illness requiring hospitalization.
Medical Indications:
- Acute medical illness
- Expected bed rest ≥3 days
- Medical ICU admissions
- Infectious disease treatment
High-Risk Populations
Priority assessment for patients with known VTE risk factors requiring enhanced surveillance and prophylaxis consideration.
Priority Groups:
- Cancer patients
- Previous VTE history
- Known thrombophilia
- Elderly with comorbidities
Clinical Decision Points
Key clinical scenarios where VTE risk assessment guides critical therapeutic decisions and care pathways.
Decision Points:
- Admission order sets
- Daily risk reassessment
- Discharge planning
- Contraindication evaluation
Related Calculators
PERC Calculator - Pulmonary Embolism Rule-Out Criteria
Advanced PERC (Pulmonary Embolism Rule-out Criteria) calculator with comprehensive clinical decision support, Wells Score integration, age-specific...
HealthAdvanced 6 Minute Walk Test Calculator
Comprehensive 6-minute walk test calculator with multiple prediction equations (Enright, Troosters, Iwama), clinical decision support, functional capacity...
HealthAdvanced TIMI Score for STEMI Calculator
Comprehensive TIMI risk score calculator for ST-elevation myocardial infarction with enhanced clinical decision support, multiple validation studies, risk...
HealthWells Score Calculator for Pulmonary Embolism
Advanced Wells Score calculator for pulmonary embolism risk assessment with comprehensive clinical decision support, D-dimer integration, Geneva Score...
HealthAge-Adjusted D-Dimer Calculator for VTE Exclusion
Calculate age-adjusted D-dimer thresholds for pulmonary embolism (PE) and deep vein thrombosis (DVT) exclusion. Integrates with Wells Score and Geneva Score...
Health4T Score Calculator for Heparin-Induced Thrombocytopenia (HIT)
Comprehensive 4T Score calculator for assessing the pre-test probability of Heparin-Induced Thrombocytopenia (HIT). Evaluates thrombocytopenia severity...
Health